What causes sepsis-induced cardiomyopathy and what new treatments are available for it?
Sepsis-induced cardiomyopathy (SCM) is a serious heart complication that can happen during severe sepsis. It is not fully understood, but it involves a 'cytokine storm' (massive inflammation), problems with the energy powerhouses of cells (mitochondria), and trouble handling calcium in heart cells. The good news is that SCM often gets better on its own within 7 to 10 days. Researchers are testing several new treatments, but most are still in early stages and not yet proven in large human studies.
What the research says
The causes of SCM are complex. A 2025 review explains that the main drivers are an inflammatory storm, mitochondrial dysfunction, abnormal calcium handling, and complement activation. It also points to newer ideas involving exosomes and non-coding RNAs. The review proposes that an 'energy metabolism-calcium handling' axis is key to why SCM can reverse 5. Another 2025 review adds that SCM can involve not just left ventricle problems but also right ventricle injury and diastolic dysfunction, making it more varied than once thought 9.
New treatments are being explored. The same 2025 review categorizes emerging therapies by which pathway they target: inflammation, mitochondria, or calcium. It mentions repurposing old drugs, using traditional Chinese medicine, and small active molecules or nanomedicine as promising directions 5. However, a 2025 review notes that there is no strong evidence yet that SCM needs a different treatment than other causes of heart failure, and for persistent heart dysfunction after sepsis, standard heart failure medications are the most logical approach 7.
Some specific experimental approaches are in very early stages. A 2020 lab study in rats found that a molecule called KCNQ1OT1 (a long non-coding RNA) can reduce heart injury from sepsis by controlling another molecule (miR-192-5p) and protecting heart cells from death 8. This is far from human use. Other sources in your set discuss different types of cardiomyopathy (like from Duchenne muscular dystrophy or transthyretin amyloid) and do not apply to sepsis-induced cardiomyopathy 46.
What to ask your doctor
- If I have had sepsis, what signs of heart problems should I watch for?
- Are there any new treatments for sepsis-induced cardiomyopathy that might be right for me?
- How is sepsis-induced cardiomyopathy different from other types of heart failure?
- What tests (like echocardiogram) can check my heart function after sepsis?
- Should I be on standard heart failure medications if my heart function does not fully recover?
This question is drawn from common patient questions about Cardiology and answered using cited medical research. We do not provide individualized advice.